- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Ophthalmology Times RWAP 2015
Guidelines for Case Study Submissions
Guidelines for Case Study Submissions
Residents are required to submit a Case Study to Ophthalmology Times (See attached Case Study Example) that includes a write-up of about 1,000 words on an ocular surface disease case, along with an abstract and PowerPoint Presentation (7 to 9 minutes in length) by Monday, August 17th, 2015.
The case study must focus on a pharmacological approach as it relates to an ocular surface disease patient. Failure to meet this requirement will result in elimination from the program.
The case study and abstract should be written using a Word software application. The abstract should include an overview of the case study, noting the patient’s symptom(s), diagnosis, and treatment. Please remember to remove patients’ names from any clinical data that you submit (per HIPPA regulations).
The Case Study should include:
History
Describe in detail the case history of a patient who has presented at the resident’s institution. Include a review of the patient’s symptoms and medical history as they pertain to this particular case. Note possible complications and standard treatment methods.
Examination
Provide the results from a thorough ophthalmologic examination of the patient. Note any findings of particular significance to this case.
Discussion and diagnosis
Present a discussion of the problem this patient poses. The discussion should be specific and practical. The situation should let the OT Review Board and readers examine the problem and the problem-solving process and learn a lesson from others’ experience.
Conclusion
Explain the significance or importance of this case to ophthalmology.
References
References should follow text and be numbered consecutively by their order of appearance in the text. Journals should be referenced in the following format:
Massry GG, Hornblass A, Harrison W. Itraconazole in the treatment of orbital aspergillosis. Ophthalmology 1996;103:1467-1470.
Submit all materials to:
Tiffany Thompson
Coordinator, Custom Project Solutions
485F US 1 South- Suite 210
Iselin, NJ 08830
732.346.3060
